載入...

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder

BACKGROUND: Major depressive disorder (MDD) is a serious illness in children and adolescents. Vilazodone is a selective serotonin reuptake inhibitor approved for MDD in adults. This study evaluated the efficacy, safety, and tolerability of vilazodone in adolescent patients, ages 12–17 years, with MD...

全面介紹

Na minha lista:
書目詳細資料
發表在:Paediatr Drugs
Main Authors: Durgam, Suresh, Chen, Changzheng, Migliore, Raffaele, Prakash, Chandran, Edwards, John, Findling, Robert L.
格式: Artigo
語言:Inglês
出版: Springer International Publishing 2018
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6028869/
https://ncbi.nlm.nih.gov/pubmed/29633166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40272-018-0290-4
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!